PROS1 and COVID-19: Various neutralizing mAbs, directed against the SARS-CoV-2 S protein and designed to block viral attachment and entry into human cells, thus neutralizing the virus and potentially preventing and treating COVID-19, have been approved for the treatment of COVID-19.